Shanghai, China: April 16th, 2021, The Fifth Future Healthcare VB100 Conference enlisted Zhimeng Biopharma as one of the Top 100 Biotech Companies in China. The listing recognizes the company's "strong potential in growth in both R&D and capital field."
"It is an extraordinary milestone achieved by our company," says Dr. Zhijun Zhang, CSO of Zhimeng Biopharma. "Our next goal will be Top 50!"
According to the Conference's website, the selection of this list was among non-public Chinese companies in the biopharmaceutical arena. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry, both present, and future.